dichloroacetic acid has been researched along with Stomach Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, T; Liu, C; Liu, Y; Shang, W; Ye, A | 1 |
| Goto, S; Kamigaki, T; Saito, M; Yano, K | 1 |
| Cho, YK; Ham, IH; Han, SU; Hur, H; Kim, YB; Lee, G; Lee, JY; Shim, W; Xuan, Y; Yun, J | 1 |
| Ham, IH; Han, SU; Hur, H; Kim, YB; Lee, G; Shim, W; Xuan, Y; Yun, J | 1 |
4 other study(ies) available for dichloroacetic acid and Stomach Neoplasms
| Article | Year |
|---|---|
Single-Cell Multimodal Analytical Approach by Integrating Raman Optical Tweezers and RNA Sequencing.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dichloroacetic Acid; Humans; Paclitaxel; Sequence Analysis, RNA; Single-Cell Analysis; Spectrum Analysis, Raman; Stomach Neoplasms | 2020 |
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Dichloroacetic Acid; Docetaxel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hyperthermia, Induced; Irinotecan; Ovarian Neoplasms; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Photosensitizing Agents; Prognosis; Silicates; Stomach Neoplasms; Taxoids; Tegafur; Titanium | 2013 |
Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism.
Topics: Adult; Aged; Cell Hypoxia; Cell Line, Tumor; Dichloroacetic Acid; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluorouracil; Glucose; Glycolysis; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Stomach Neoplasms | 2014 |
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Blotting, Western; Carcinoma, Signet Ring Cell; Cell Survival; Dichloroacetic Acid; Female; Fluorouracil; Glucose; Glucose Transporter Type 1; Glycolysis; Hexokinase; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; Lactic Acid; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Stomach Neoplasms; Survival Rate; Tissue Array Analysis; Tumor Cells, Cultured | 2013 |